Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PDL BIOPHARMA INC Cash Flow

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Net Income/Starting Line 68.39 M -21.06 M -130.02 M -166.58 M -53.24 M
    Operating Activities
    Depreciation, Depletion & Amortization 22.49 M 64.49 M 75.67 M 52.68 M 13.86 M
    Depreciation & Depletion 20.91 M 32.15 M 30.82 M 15.13 M 11.36 M
    Amortization of Intangible Assets 1.58 M 32.34 M 44.85 M 37.56 M 2.50 M
    Deferred Income Taxes and Investment Tax credity 1.50 M 27.65 M 31.37 M 57.74 M 0.00
    Deferred Income Taxes 1.50 M 27.65 M 31.37 M 57.74 M 0.00
    Income Tax Credit
    Other Cash Flow 30.42 M 29.20 M 101.60 M 115.68 M 2.16 M
    Funds from Operations 99.40 M 72.63 M 47.25 M 1.78 M -37.22 M
    Extraordinary Items & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
    Funds from/for Other Operating Activities -19.25 M -5.66 M 31.52 M 29.76 M 10.06 M
    Incline (Decline) in Receivables 5.68 M 10.82 M 2.88 M -24.15 M 340,000.00
    Incline (Decline) in Inventories -4.22 M -2.11 M 923,000.00 0.00 0.00
    Incline (Decline) in Accounts Payable -7.18 M -4.58 M 10.75 M -4.03 M 1.28 M
    Incline (Decline) in Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Incline (Decline) in Other Accruals -32.35 M -4.15 M 30.22 M 13.62 M -9.63 M
    Incline (Decline) in Other Assets or Liabilties 14.60 M -3.53 M -10.22 M 43.40 M 18.07 M
    Net Cash Flow/Operating Activities 80.15 M 66.97 M 78.77 M 31.55 M -27.16 M
    Capital Expenditures (Additions to Fixed Assets)
    Additions to Other Assets 0.00 0.00 18.78 M 0.00 0.00
    Net Assets from Acquisitions 0.00 0.00 0.00 432.56 M 0.00
    Incline (Decline) in Inventories 15.00 M 134.59 M 384.21 M 600,000.00 291.27 M
    Decrease in Investments 70.78 M 291.08 M 308.76 M 154.54 M 146.78 M
    Disposal of Fixed Assets 509.50 M 20.90 M 269,000.00 0.00 0.00
    Other Uses - Investing -25.00 M 10.00 M -14.48 M 873,000.00 0.00
    Other Sources - Investing 25.00 M 0.00 32.75 M 0.00 0.00
    Net Cash Flow - Investing -587.02 M -72.66 M 115.99 M 320.76 M 240.18 M
    Proceeds from Stock Options 15.39 M 27.27 M 33.53 M 139.87 M 18.31 M
    Other Proceeds from Sale/Issues of Stock 0.00 0.00 0.00 0.00 0.00
    Com/Pfd Purchase, Retired, Converted, Redeemed 0.00 0.00 0.00 0.00 0.00
    Financing Activities
    Long Term Borrowings 0.00 0.00 0.00 242.05 M 0.00
    Incline or Decline in Short Term Borrowings 0.00 0.00 0.00 0.00 0.00
    Reduction in Long Term Debt 667,000.00 7.39 M 675,000.00 721,000.00 1.35 M
    Cash Dividends Paid Total 506.61 M 0.00 0.00 0.00 0.00
    Common Dividends (Cash) 506.61 M 0.00 0.00 0.00 0.00
    Preferred Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Other Sources - Financing 19.32 M 2.12 M 0.00 0.00 0.00
    Other Uses - Financing -386.65 M 2.12 M 0.00 0.00 0.00
    Net Cash Flow - Financing -878.54 M 22.00 M 32.85 M 381.20 M 16.96 M
    Effect of Exchange rate on Cash
    Changes in Cash and/or Liquid Items